Pradeep Sharma & Anr v. UPL Ltd

178688626

The petitioner challenged an order restraining him from infringing the respondent's patents related to synergistic herbicidal compositions (Metsulfuron Methyl and Sulfosulfuron). The dispute centered on whether the composition used by the appellant fell within the scope of the plaintiff's patented claims. The court ultimately upheld the Single Judge's finding that prima facie, the defendant's product was covered by the suit patent.

Jurisdiction
India
Court
Delhi High Court
Case Number
178688626
Judge(s)
S. Ravindra Bhat,A. K. Chawla

Detailed Summary

In the high-stakes world of agrochemical patents, the line between a legitimate generic alternative and an infringing copy can be razor-thin. When Pradeep Sharma found himself on the wrong side of that line, he learned a hard lesson: challenging a patent injunction at the appellate level is an uphill battle when the trial judge has already done the technical homework. This case is a cautionary tale for any founder or manufacturer who assumes that an appeal will automatically overturn a lower court's ruling on patent scope.

The dispute pitted Pradeep Sharma and an associate against UPL Ltd, a major player in the agrochemical industry. At the heart of the conflict were patents covering synergistic herbicidal compositions — specifically formulations involving Metsulfuron Methyl and Sulfosulfuron, two active ingredients commonly used in weed-control products for cereal crops. UPL Ltd held patents on these synergistic combinations and alleged that Sharma's product fell squarely within the scope of their protected claims. When UPL moved for an injunction, a Single Judge granted the order restraining Sharma from continuing to manufacture or sell the allegedly infringing composition. Dissatisfied, Sharma appealed to a higher bench, seeking to overturn the restraint order.

Sharma's primary argument on appeal was that the composition he was using did not actually fall within the scope of UPL's patented claims — essentially contending that his formulation was different enough to escape infringement. He challenged the Single Judge's assessment, suggesting that the lower court had erred in its prima facie evaluation of the technical overlap between his product and the suit patent. UPL Ltd, on the other hand, maintained that the Single Judge had correctly applied the legal tests for patent infringement at the interlocutory stage. UPL argued that the technical evidence on record demonstrated that Sharma's herbicide composition was covered by the claims of the suit patent, and that the injunction was properly granted to protect its intellectual property rights during the pendency of the suit.

The appellate court sided with UPL Ltd and upheld the Single Judge's order. The court found that the Single Judge had correctly applied the relevant legal tests in arriving at a prima facie conclusion that Sharma's product was covered by the suit patent. Critically, the appellate bench emphasized the well-established principle that an appellate court should be circumspect in interfering with a single judge's prima facie decision on an interlocutory matter, particularly when the correct legal standards have been applied. Because the lower court's reasoning was sound and the technical assessment supported the finding of likely infringement, there was no basis to disturb the injunction. Sharma's appeal failed, and the restraint order against him stood.

For founders, manufacturers, and IP professionals, this case delivers a clear strategic message: winning at the appellate stage in a patent dispute is not about re-arguing the facts — it is about showing that the lower court applied the wrong legal test or committed a clear error. If you are developing a product that even arguably overlaps with an existing patent, conduct a thorough freedom-to-operate analysis before launch. And if you find yourself on the receiving end of an injunction, understand that appellate courts give significant deference to a trial judge's technical prima facie findings. The real battle is won or lost at the trial level, not on appeal.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court. Understanding the court's reasoning in Pradeep Sharma & Anr vs UPL Ltd is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patent199253849

Master Arnesh Shaw Through His Next Friend And ...vsUnion Of India & Anr.

The petition addressed the cumbersome and long-drawn process for procuring specialized medicines for DMD patients on a patient-by-patient basis. The court directed M/s. Sarepta to document a bulk procurement process and provide details of all its relevant Indian patents and patent applications.

patent150941715

Dhanpat Seth And OthersvsM/S Nilkamal Plastic Ltd

The plaintiffs filed a suit seeking an injunction and damages, alleging that the defendant infringed their Patent No. 195917 for a device used for manually hauling agricultural produce. The court examined the patent's validity and found that the invention lacked inventive step, as it was merely a substitution of bamboo with plastic in a traditionally known item (Kilta).

patent2464994

Novartis AgvsAtoz Pharmaceuticals Pvtltd

Novartis Ag filed a civil suit seeking a permanent injunction and damages against Atoz Pharmaceuticals Pvt Ltd and Zota Pharmaceuticals Pvt Ltd for alleged infringement of its Indian Patent No. 212815 concerning Vildagliptin API/formulations. The court noted that the defendant had cancelled the product 'VILDAPIN-50' as requested by them, leading to the plaintiffs withdrawing most reliefs.

patent10753573

Dr. Aloys WobbenvsShri Yogesh Mehra & Ors.

The plaintiff sought to prevent the defendants from filing applications for the revocation or cancellation of the plaintiff's patents. The plaintiff argued that the defendant was barred by the doctrine of election since they had already pursued their statutory rights elsewhere. The court held that the defendant is entitled to pursue independent statutory remedies, even if overlapping with defenses in a suit.

patent153209321

Gilead Pharmasset, LlcvsUnion Of India & Anr

Gilead Pharmasset challenged an order passed by the Patent Office, arguing that it violated natural justice because the decision considered grounds and material from pre-grant oppositions (filed under Section 25) without giving the petitioner a hearing. The court found that the availability of this opposition material created a potential for bias, leading to the setting aside of the impugned order.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call